- Home
- OSUR vs CBAN Comparison
OSUR vs CBAN Comparison
Compare OSUR & CBAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSUR
- CBAN
- Stock Information
- Founded
- OSUR 2000
- CBAN 1975
- Country
- OSUR United States
- CBAN United States
- Employees
- OSUR N/A
- CBAN N/A
- Industry
- OSUR Medical/Dental Instruments
- CBAN Major Banks
- Sector
- OSUR Health Care
- CBAN Finance
- Exchange
- OSUR Nasdaq
- CBAN Nasdaq
- Market Cap
- OSUR 289.4M
- CBAN 285.3M
- IPO Year
- OSUR 1986
- CBAN 1998
- Fundamental
- Price
- OSUR $3.92
- CBAN $16.00
- Analyst Decision
- OSUR Hold
- CBAN
- Analyst Count
- OSUR 2
- CBAN 0
- Target Price
- OSUR $5.50
- CBAN N/A
- AVG Volume (30 Days)
- OSUR 914.1K
- CBAN 45.4K
- Earning Date
- OSUR 02-25-2025
- CBAN 01-22-2025
- Dividend Yield
- OSUR N/A
- CBAN 2.82%
- EPS Growth
- OSUR N/A
- CBAN 1.70
- EPS
- OSUR 0.15
- CBAN 1.25
- Revenue
- OSUR $224,263,000.00
- CBAN $108,949,000.00
- Revenue This Year
- OSUR N/A
- CBAN N/A
- Revenue Next Year
- OSUR N/A
- CBAN $6.05
- P/E Ratio
- OSUR $25.69
- CBAN $12.77
- Revenue Growth
- OSUR N/A
- CBAN N/A
- 52 Week Low
- OSUR $3.52
- CBAN $10.33
- 52 Week High
- OSUR $8.04
- CBAN $18.49
- Technical
- Relative Strength Index (RSI)
- OSUR 57.58
- CBAN 50.02
- Support Level
- OSUR $3.52
- CBAN $16.09
- Resistance Level
- OSUR $3.80
- CBAN $16.18
- Average True Range (ATR)
- OSUR 0.14
- CBAN 0.39
- MACD
- OSUR 0.03
- CBAN 0.06
- Stochastic Oscillator
- OSUR 93.02
- CBAN 75.54
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.
About CBAN Colony Bankcorp Inc.
Colony Bankcorp Inc is a bank holding company. The bank provides a broad range of banking services to its retail and commercial customers. Its product line includes loans to small and medium-sized businesses, residential and commercial construction and land development loans, commercial real estate loans, agri-business and production loans, residential mortgage loans, consumer loans, and a variety of demand, savings, and time deposit products. The company's segments include the Banking Division, Retail Mortgage Division, and small business specialty lending divisions. It generates maximum revenue from the Banking Division.